Even though changes in <i>SPI1</i> expression have been associated with acute myeloid leukemia (AML), the structural and regulatory effects of missense mutations at the PU.1 ETS domain have not been entirely studied, and targeting the PU.1 ETS domain by ligands is an area of computational analysis that should be further pursued. This evidence concerns the gene SPI1 and acute myeloid leukemia.